Studies by Agner et al. revealed that the TC value of triple-negative breast cancer was significantly higher than that of HER2-positive breast cancer, suggesting that the edge of triple-negative breast cancer is smoother than HER2-positive breast cancer [24]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.